Molecular Partners Ag (MOLN) Exchange Rate Effect (2020 - 2026)
Molecular Partners Ag (MOLN) posted quarterly Exchange Rate Effect of $77.9 for Q1 2026, up 183.38% year-on-year from $27.49 in Q1 2025, and up 100.0% on a QoQ basis from -$1.7 million in Q4 2025.
Molecular Partners Ag (MOLN) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Exchange Rate Effect for 7 consecutive years, with $77.9 the latest figure, recorded in Q1 2026.
- Quarterly Exchange Rate Effect rose 183.38% year-over-year to $77.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.7 million (down 267.24% YoY) and the FY2025 annual result came in at -$1.7 million, down 267.23% from the prior year.
- Exchange Rate Effect grew to $77.9 in Q1 2026 per MOLN's latest filing, from -$1.7 million in the prior quarter.
- Over the last five years, Exchange Rate Effect for MOLN reached as high as $1.0 million in Q4 2024 and fell as low as -$5.8 million in Q4 2023.
- A 5-year average of -$363428.7 and a median of $1.21 in 2025 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2023 — Exchange Rate Effect sank 2247.64% — and 2024, when it surged 4924.64%.
- Year by year, Exchange Rate Effect stood at $267818.0 in 2022, then plunged by 2247.64% to -$5.8 million in 2023, then surged by 117.74% to $1.0 million in 2024, then tumbled by 267.23% to -$1.7 million in 2025, then jumped by 100.0% to $77.9 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $77.9, -$1.7 million, and $3.75 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - | 77.90 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77.90 |
| Mar 31, 2026 | 77.90 |
| Dec 31, 2025 | -1.71 Mn |
| Dec 31, 2025 | -1.71 Mn |
| Sep 30, 2025 | 3.75 |
| Sep 30, 2025 | 3.75 |
| Jun 30, 2025 | 1.21 |
| Jun 30, 2025 | 1.21 |
| Mar 31, 2025 | -93.43 |
| Mar 31, 2025 | -93.43 |
| Dec 31, 2024 | 1.02 Mn |
| Dec 31, 2024 | 1.02 Mn |
| Sep 30, 2024 | -6.93 |
| Sep 30, 2024 | -6.93 |
| Jun 30, 2024 | -5.53 |
| Jun 30, 2024 | -5.53 |
| Mar 31, 2024 | 886.76 |
| Mar 31, 2024 | 886.76 |
| Dec 31, 2023 | -5.75 Mn |
| Dec 31, 2023 | -5.75 Mn |